Medidata Reports Full-Year and Fourth Quarter 2015 Results

Go back to Medidata Reports Full-Year and Fourth Quarter 2015 Results

Needham & Company Remains Bullish on Medidata Solutions (MDSO) Despite Revenue Shortfall

February 11, 2016 8:35 AM EST

Needham & Company maintained a Buy rating on Medidata Solutions (NASDAQ: MDSO), and cut the price target to $45.00 (from $65.00), following the company's 4Q earnings report. Despite MDSO's reported revenue shortfall (missed Street estimates by $6MM), Needham would characterize leading indicators as somewhat encouraging. Needham analysts... More

Medidata Solutions (MDSO) PT Lowered to $35 at Jefferies

February 11, 2016 8:20 AM EST

Jefferies analyst David Windley reiterated a Hold rating and lowered his price target on Medidata Solutions (NASDAQ: MDSO) to $35.00 (from $42.00) following Q4 results.

Windley commented, "Our LT concerns remain regarding the size of MDSO's TAM, as well as demand durability from small... More

Medidata Solutions (MDSO) Tops Q4 EPS by 3c

February 10, 2016 6:35 AM EST

Medidata Solutions (NASDAQ: MDSO) reported Q4 EPS of $0.27, $0.03 better than the analyst estimate of $0.24. Revenue for the quarter came in at $98.9 million versus the consensus estimate of $105.09 million.

GUIDANCE:

Medidata Solutions sees FY2016 revenue of $450-474 million, versus the consensus of... More